{"id":9499,"date":"2022-05-04T22:31:14","date_gmt":"2022-05-04T22:31:14","guid":{"rendered":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/pcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations\/"},"modified":"2022-05-10T14:20:00","modified_gmt":"2022-05-10T14:20:00","slug":"pcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations","status":"publish","type":"the-bmj-article","link":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/pcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations\/","title":{"rendered":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events"},"featured_media":0,"template":"","categories":[],"tags":[],"content_type":[35],"editorial_panel":[],"channel_page":[42],"class_list":["post-9499","the-bmj-article","type-the-bmj-article","status-publish","hentry","article-type-practice","channel-page-education"],"aioseo_notices":[],"meta_box":{"the_bmj_article-url":"\/content\/377\/bmj-2021-069066","the_bmj_article-description":"Additional cholesterol lowering drugs should be offered to patients with high levels of LDL cholesterol who are also at high risk of heart disease, recommend an international panel","the_bmj_article-the_bmj_article_image":[{"width":150,"height":150,"file":"2022\/05\/rr_lipids_textless_v5.png","sizes":{"medium":{"file":"rr_lipids_textless_v5-300x194.png","width":300,"height":194,"mime-type":"image\/png","url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2022\/05\/rr_lipids_textless_v5-300x194.png"},"thumbnail":{"file":"rr_lipids_textless_v5-150x150.png","width":150,"height":150,"mime-type":"image\/png","url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2022\/05\/rr_lipids_textless_v5-150x150.png"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0","keywords":[]},"ID":"9513","name":"rr_lipids_textless_v5.png","path":"\/dom34810\/wp-content\/uploads\/sites\/4\/2022\/05\/rr_lipids_textless_v5.png","url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2022\/05\/rr_lipids_textless_v5-150x150.png","full_url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2022\/05\/rr_lipids_textless_v5.png","title":"rr_lipids_textless_v5","caption":"","description":"","alt":"infographic","srcset":false}],"the_bmj_article-related_articles":[{"article_type":"Research","related_article_title":"PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction","related_article_url":"https:\/\/www.bmj.com\/content\/377\/bmj-2021-069116"},{"article_type":"Research","related_article_title":"Safety of ezetimibe in lipid-lowering treatment","related_article_url":"https:\/\/bmjmedicine.bmj.com\/content\/1\/1\/e000134"}],"the_bmj_article-journal_name":"BMJ Medicine"},"head_tags":[{"tag":"title","content":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events | The BMJ"},{"tag":"meta","attributes":{"name":"robots","content":"max-image-preview:large"}},{"tag":"link","attributes":{"rel":"canonical","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/pcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations\/"}},{"tag":"meta","attributes":{"name":"generator","content":"All in One SEO (AIOSEO) 4.9.7.2"}},{"tag":"meta","attributes":{"property":"og:locale","content":"en_GB"}},{"tag":"meta","attributes":{"property":"og:site_name","content":"The BMJ | The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"property":"og:type","content":"article"}},{"tag":"meta","attributes":{"property":"og:title","content":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events | The BMJ"}},{"tag":"meta","attributes":{"property":"og:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/pcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations\/"}},{"tag":"meta","attributes":{"property":"article:published_time","content":"2022-05-04T22:31:14+00:00"}},{"tag":"meta","attributes":{"property":"article:modified_time","content":"2022-05-10T14:20:00+00:00"}},{"tag":"meta","attributes":{"name":"twitter:card","content":"summary"}},{"tag":"meta","attributes":{"name":"twitter:title","content":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events | The BMJ"}},{"tag":"link","attributes":{"rel":"alternate","type":"application\/rss+xml","title":"The BMJ \u00bb Feed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/feed\/"}},{"tag":"link","attributes":{"rel":"alternate","type":"application\/rss+xml","title":"The BMJ \u00bb Comments Feed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/comments\/feed\/"}},{"tag":"link","attributes":{"rel":"alternate","title":"oEmbed (JSON)","type":"application\/json+oembed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/oembed\/1.0\/embed?url=https%3A%2F%2Fbmj-chicken.bmj.com%2Fthebmj%2Fthe-bmj-article%2Fpcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations%2F"}},{"tag":"link","attributes":{"rel":"alternate","title":"oEmbed (XML)","type":"text\/xml+oembed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/oembed\/1.0\/embed?url=https%3A%2F%2Fbmj-chicken.bmj.com%2Fthebmj%2Fthe-bmj-article%2Fpcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations%2F&format=xml"}},{"tag":"link","attributes":{"rel":"https:\/\/api.w.org\/","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/"}},{"tag":"link","attributes":{"rel":"alternate","title":"JSON","type":"application\/json","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article\/9499"}},{"tag":"link","attributes":{"rel":"EditURI","type":"application\/rsd+xml","title":"RSD","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/xmlrpc.php?rsd"}},{"tag":"meta","attributes":{"name":"generator","content":"WordPress 6.9.4"}},{"tag":"link","attributes":{"rel":"shortlink","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/?p=9499"}},{"tag":"meta","attributes":{"property":"og:locale","content":"en_GB"}},{"tag":"meta","attributes":{"property":"og:site_name","content":"The BMJ"}},{"tag":"meta","attributes":{"property":"og:title","content":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events"}},{"tag":"meta","attributes":{"property":"og:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/pcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations\/"}},{"tag":"meta","attributes":{"property":"og:type","content":"article"}},{"tag":"meta","attributes":{"property":"og:description","content":"The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"name":"twitter:title","content":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events"}},{"tag":"meta","attributes":{"name":"twitter:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/pcsk9-inhibitors-and-ezetimibe-for-the-reduction-of-cardiovascular-events-a-clinical-practice-guideline-with-risk-stratified-recommendations\/"}},{"tag":"meta","attributes":{"name":"twitter:description","content":"The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"name":"twitter:card","content":"summary_large_image"}}],"_links":{"self":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article\/9499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article"}],"about":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/types\/the-bmj-article"}],"type":[{"embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/types\/the-bmj-article"}],"wp:attachment":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/media?parent=9499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/categories?post=9499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/tags?post=9499"},{"taxonomy":"article-type","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/content_type?post=9499"},{"taxonomy":"editorial-panel","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/editorial_panel?post=9499"},{"taxonomy":"channel-page","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/channel_page?post=9499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}